Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (181-190 of 542) with videos related to

Pageof 55
Sort By:
Bone Marrow Transplantation|November 1, 1989
Disseminated Fusarium infections in patients following bone marrow transplantationR L Minor, M A Pfaller, R D Gingrich, et al.
Diagnostic Microbiology and Infectious Disease|May 8, 1998
Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE programS A Marshall, W W Wilke, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease|January 13, 1999
Antimicrobial activity of gatifloxacin tested against 1676 strains of ciprofloxacin-resistant gram-positive cocci isolated from patient infections in North and South AmericaR N Jones, M L Beach, M A Pfaller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1996
Use of macrorestriction analysis to demonstrate interhospital spread of multiresistant Acinetobacter baumannii in São Paulo, BrazilH S Sader, C F Mendes, A C Pignatari, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformansM A Pfaller, S A Messer, R J Hollis, et al.
The American Journal of Medicine|September 16, 1991
Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measuresR P Wenzel, M D Nettleman, R N Jones, et al.
Infection Control and Hospital Epidemiology|February 1, 1992
Molecular epidemiology of coagulase-negative staphylococci isolated from immunocompromised patientsL A Herwaldt, R J Hollis, L D Boyken, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1997
A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents. A 187 clinical laboratory center sample in the United StatesR N Jones, M R Jacobs, J A Washington, et al.
American Journal of Infection Control|August 1, 1990
In vitro comparison of mezlocillin and piperacillin plus tobramycin or gentamicin versus 100 gram-negative nosocomial bloodstream isolatesI Cabezudo, M A Pfaller, M Barrett, et al.
American Journal of Clinical Pathology|August 1, 1987
Variation from standards in Staphylococcus aureus susceptibility testingM A Pfaller, D S Wakefield, G T Hammons, et al.
Pageof 55

Showing results (181-190 of 542) with videos related to

Sort By:
Pageof 55
Bone Marrow Transplantation|November 1, 1989
Disseminated Fusarium infections in patients following bone marrow transplantationR L Minor, M A Pfaller, R D Gingrich, et al.
Diagnostic Microbiology and Infectious Disease|May 8, 1998
Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE programS A Marshall, W W Wilke, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease|January 13, 1999
Antimicrobial activity of gatifloxacin tested against 1676 strains of ciprofloxacin-resistant gram-positive cocci isolated from patient infections in North and South AmericaR N Jones, M L Beach, M A Pfaller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1996
Use of macrorestriction analysis to demonstrate interhospital spread of multiresistant Acinetobacter baumannii in São Paulo, BrazilH S Sader, C F Mendes, A C Pignatari, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformansM A Pfaller, S A Messer, R J Hollis, et al.
The American Journal of Medicine|September 16, 1991
Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measuresR P Wenzel, M D Nettleman, R N Jones, et al.
Infection Control and Hospital Epidemiology|February 1, 1992
Molecular epidemiology of coagulase-negative staphylococci isolated from immunocompromised patientsL A Herwaldt, R J Hollis, L D Boyken, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1997
A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents. A 187 clinical laboratory center sample in the United StatesR N Jones, M R Jacobs, J A Washington, et al.
American Journal of Infection Control|August 1, 1990
In vitro comparison of mezlocillin and piperacillin plus tobramycin or gentamicin versus 100 gram-negative nosocomial bloodstream isolatesI Cabezudo, M A Pfaller, M Barrett, et al.
American Journal of Clinical Pathology|August 1, 1987
Variation from standards in Staphylococcus aureus susceptibility testingM A Pfaller, D S Wakefield, G T Hammons, et al.
Pageof 55